Compare TIL & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TIL | MIST |
|---|---|---|
| Founded | 2018 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.2M | 95.3M |
| IPO Year | 2021 | 2019 |
| Metric | TIL | MIST |
|---|---|---|
| Price | $5.49 | $0.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $3.86 |
| AVG Volume (30 Days) | 72.1K | ★ 1.7M |
| Earning Date | 11-16-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $215.89 |
| Revenue Next Year | N/A | $157.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.28 | $0.36 |
| 52 Week High | $13.50 | $3.06 |
| Indicator | TIL | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 31.93 | 30.08 |
| Support Level | N/A | N/A |
| Resistance Level | $7.67 | $0.84 |
| Average True Range (ATR) | 0.49 | 0.08 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 17.13 | 12.36 |
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.